Isryl Trio 1 Tablet - Strip of 10

Isryl Trio 1 Tablet is a specialized pharmaceutical formulation designed to assist in the management of type 2 diabetes mellitus. This medication is a combination of three active ingredients: Dapagliflozin, Glimepiride, and Metformin. Each component plays a crucial role in regulating blood sugar levels, thereby helping to mitigate the risks associated with diabetes. Dapagliflozin functions primarily by promoting the excretion of excess glucose through urine, effectively lowering blood sugar levels. Glimepiride enhances insulin production from the pancreas and improves the body's sensitivity to insulin, which is vital for glucose metabolism. Metformin complements these actions by reducing glucose absorption from the gastrointestinal tract and decreasing hepatic glucose production. The therapeutic purpose of Isryl Trio 1 Tablet is to control hyperglycemia in patients with type 2 diabetes, thereby reducing the likelihood of serious complications such as kidney damage, neuropathy, and cardiovascular diseases. It is important to note that Isryl Trio 1 Tablet should be integrated into a comprehensive treatment plan that includes dietary modifications, regular physical activity, and weight management as advised by healthcare professionals. Patients are encouraged to adhere to their prescribed dosage and schedule to achieve optimal results. Isryl Trio 1 Tablet can be taken with or without food, but consistency in timing is key to maintaining stable blood sugar levels. Discontinuation of this medication without medical guidance may lead to increased blood sugar levels and heightened risk of complications. Therefore, it is essential for patients to consult their healthcare provider before making any changes to their medication regimen.